Skip to main content
. Author manuscript; available in PMC: 2014 Feb 11.
Published in final edited form as: Cancer Cell. 2013 Feb 11;23(2):186–199. doi: 10.1016/j.ccr.2012.12.020

Table 1.

Clinicopathologic Information of the OvCa Patient Cohorts

TCGA Tothill Bonome Bentink# Tianjin Bagnoli
Number 459 246 185 129 92 55
Age (SD) Stage 60 (11) 60 (10) 62 (12) 61 (14) 55.5 (12) 56 (12)
 II 23 10 0 1 15 0
 III 359 199 144 109 63 45
 IV 73 21 41 19 7 10
Tumor Grade
 G2 57 88 40 NA 43 7
 G3 392 145 144 NA 47 43
Surgical Outcome
 Optimal 289 131 90 98 50 24
 Suboptimal 114 65 95 28 42 31
Vital Status
 Living 203 132 56 56 47 23
 Deceased 251 110 129 73 45 32
Follow Up
 Median (Range) 31 (1-179) 28 (1-214) 38 (1-164) 31 (1-91) 25 (1-79) 36 (7-91)
Subtype
 iE 287 140 102 71 NA* NA*
 iM 172 102 83 58 NA* NA*
Source TCGA GSE9891 GSE26712 MTAB386 TCH@ GSE25204

Note: Numbers do not add up because of missing information in some cases.

#

For Bentink Dataset, both mRNA and miRNA microarray data are available

*

No iM/iE subtype was assigned because only miRNA expression data is available.

@

Tianjin Cancer Hospital